CLUSTER filed Aug 11, 2026 at 06:30 ET
ResMed's CEO Michael Farrell and Director Peter Farrell sold a combined $2.83M in open-market shares over a 3-day window. The CEO's sale ($1.03M at ~$205.69) followed a same-day option exercise at a lower strike, a classic cashless exercise pattern. The Director's sale ($1.8M at $225) was a pure open-market disposition. At a $31.9B market cap, the total represents ~0.009% of market cap, trivial in size and well below the 0.1% materiality threshold. The cluster is dominated by sales, but the dollar amount is too small to carry a bearish signal, especially given the CEO's transaction is mechanically linked to option exercise.